MYC and breast carcinoma: Conversely, vascular endothelial growth factor‐alpha (VEGF) upregulates the expression of Myc and Sox2 through its receptor VEGFR‐2, thereby enhancing the self‐renewal capacity of breast cancer stem cells via the JAK2/STAT3 pathway [64].